Brain Canada Brain Canada
FR Donate

Our directory of funded grants

311 result(s) found

CFMM: Canada’s National Ultra-High Field MRI Platform

Project Overview

Brain imaging using magnetic resonance imaging (MRI) is an essential tool in modern neuroscience, with many uses for examining brain structure and function in health and disease. The Centre for Functional and Metabolic Mapping (CFMM) at Western’s Robarts Research Institute houses Canada’s only c…

See researchers on this project
Principal Investigator:
  • Ravi Menon, University of Western Ontario
Team Members:
  • Robert Bartha, Robarts Research Institute
  • Stefan Everling, University of Western Ontario
  • Elizabeth Finger, University of Western Ontario
  • Adrian Owen, University of Western Ontario
  • Jody Culham, University of Western Ontario
  • Lena Palaniyappan, London Health Sciences Centre
  • Corey Baron, Western University
  • Marieke Mur, Western University
  • Ali Kahn, Western University

Characterization of a novel medulloblastoma tumor suppressor

Project Overview

Medulloblastoma is a pediatric cancer of the brain and is the most common solid tumour in children. Currently, the standard therapy for medulloblastoma remains nonspecific to the cancer subtype and consists of surgery followed by chemotherapy and/or craniospinal irradiation. Due to these treatments,…

See researchers on this project
Principal Investigator:
  • Sabrina Schlienger, IRCM

Characterization of MATR3 Mutations Associated with ALS

Project Overview

For this project, Dr. Park will examine how abnormalities in RNA binding proteins (RBPs) – in particular, one called Matrin 3 (MATR3) – can lead to ALS. MATR3 was discovered to be a genetic cause of ALS in 2014 and has yet to be studied in any detail. By creating the first-ever cell, fruit fly a…

See researchers on this project
Principal Investigator:
  • Jeehye Park, University of Toronto

Characterization of the role of LRRTMs in synaptic plasticity and memory formation

Project Overview

Dr. Connor’s projects have focused on elucidating the mechanisms governing synapse development, and how synaptic dysfunction is associated with neurologic disorders. Specifically, he has been investigating the role of synaptic adhesion proteins (SAPs), and uncovering the role of these proteins in …

See researchers on this project
Principal Investigator:
  • Steven Connor, University of British Columbia

Characterizing Enterovirus Disruption of Autophagy as a Disease Mechanism for ALS

Project Overview

A group of viruses called enteroviruses can cause a variety of infectious illnesses that are usually mild with symptoms that may include fever, respiratory distress, flu-like muscle aches and rashes. However, some enteroviruses are more serious, like enterovirus D68 that can cause severe respiratory…

See researchers on this project
Principal Investigator:
  • Yasir Mohamud, University of British Columbia - Providence Health Care Society

Characterizing the C9ORF72 protein interactome for identifying novel pathogenic pathways in ALS

Project Overview

In late 2011, a landmark discovery was made which identified that abnormalities (mutation) in a gene called C9ORF72 were responsible for the highest percentage of hereditary ALS and frontotemporal dementia cases. Since then, a lot of work has been done to understand how these mutations cause disease…

See researchers on this project
Principal Investigator:
  • Janice Robertson, University of Toronto

Co-clinical trials in mice and humans in autism

Project Overview

Autism has many causes, yet no single cause explains why many children and adults have autism. This makes treating the symptoms of autism difficult, since how somebody responds to treatment might depend on what cause autism in the first place. We thus need both better treatments and ways of figuring…

See researchers on this project
Principal Investigator:
  • Evdokia Anagnostou,

    Holland Bloorview Kids Rehabilitation Hospital

  • Jason Lerch, University of Toronto
Team Members:
  • Jane Foster, McMaster University
  • Barry Greenberg, Krembil Research Institute
  • Robert Nicolson, University of Western Ontario
  • Teresa Bennett, McMaster University
  • Rosanna Weksberg, The Hospital For Sick Children
  • Stephen Scherer, The Hospital For Sick Children

Co-clinical trials of autism in mice and humans

Project Overview

Autism is a neuro-developmental disorder characterized by social/communication deficits and repetitive behaviours. It is very heterogeneous, with over 250 genes implicated, but is highly heritable. The current therapeutic approach is frequently ineffective partly because often a single treatment is …

See researchers on this project
Principal Investigator:
  • Zsuzsa Buchwald, University of Toronto

Cognitive Outcomes and Response/Remission Efficacy of Convulsive Therapies in Treatment Resistant Depression: The CORRECT-TRD Trial

Project Overview

Magnetic Seizure Therapy (MST) is a novel form of treatment that uses high intensity magnetic field pulses to stimulate the brain and induce a seizure as a therapeutic intervention for patients with depression resistant to antidepressant medication, known as Treatment Resistant Depression (TRD). Pre…

See researchers on this project
Principal Investigator:
  • Daniel Blumberger, Centre for Addiction and Mental Health
Team Members:
  • Shawn McClintock, Duke University
  • Kiran Rabheru, University of Ottawa
  • Fidel Vila-Rodriguez, University of British Columbia
  • Zafiris Daskalakis, Centre for Addiction and Mental Health
  • Sarah Lisanby, Duke University
  • Mustafa Husain, Duke University
  • Jonathan Downar, Toronto Western Research Institute, University of Toronto

Combining neurostimulation technique with tailored interventions for the affected upper extremity: can it promote better recovery in stroke survivors?

Project Overview

A substantial proportion of individuals are left with poor residual functioning of the affected arm after a stroke. This has a tremendous impact on the quality of life and the ability for stroke survivors to live independently. While exercise is considered essential to any rehabilitation program, it…

See researchers on this project
Principal Investigator:
  • Marie-Hélène Milot, Université de Sherbrooke
Team Members:
  • François Tremblay, University of Ottawa
  • Marie-Hélène Boudrias, McGill University
  • Hélène Corriveau, Université de Sherbrooke

Correction of Neuronal Function in Autism

Project Overview

The prevalence of autism spectrum disorders (ASDs) is rising dramatically on a yearly basis and new interventional strategies are required to treat ASDs and related disorders like Fragile X syndrome. Altered communication between brain cells may lead to the defects responsible for the features that …

See researchers on this project
Principal Investigator:
  • Laurie Doering, McMaster University
Team Members:
  • Min Zhuo, University of Toronto
  • Ali Pejmun Haghighi, McGill University
  • David Nelson, Baylor College of Medicine

Cortical GABAergic interneurons migration impairment in genetic epileptic encephalopathies

Project Overview

This project aims at elucidating the roles of new candidate genes in brain development, particularly in the context of refractory paediatric epilepsies (epileptic encephalopathies) and co-morbid neurodevelopmental disorders such as autism and intellectual deficiency.  Lara Eid is particularly inter…

See researchers on this project
Principal Investigator:
  • Lara Eid, CHU-Saint Justine

CRF receptor-mediated sensitization of 5-HT2A receptor signalling

Project Overview

Anxiety and depression often present as co-morbid disorders and the expression and severity of these illnesses is commonly associated with stressful experiences. Both are widespread and serious disorders that affect the lives of 10-15% of Canadians for most of their lifetime. There are multiple pote…

See researchers on this project
Principal Investigator:
  • Cornelia Walther, University of Western Ontario

Crosstalk between immune response and metabolic signaling: targeting leptin/AMPK axis to restore metabolic homeostasis in ALS

Project Overview

Increased metabolism (hypermetabolism) is a characteristic often associated with more aggressive, faster progressing cases of ALS. Recently, after studying blood plasma samples from people with more rapidly progressing disease, Dr. Jasna Kriz discovered that fast progressing individuals often have d…

See researchers on this project
Principal Investigator:
  • Jasna Kriz, Université Laval
Team Members:
  • Nicolas Dupré, CRCHUQ-Enfant-Jesus, University Laval
  • Angela Genge, McGill University

Cyto-iGluSnFR: A glutamate biosensor platform for brain diseases

Project Overview

In the human brain and retina, the chemical glutamate is a very important messenger that carries information from one neuron to another. The levels of glutamate transmitted between neurons must be tightly controlled: too high and neurons die, too low and information is not communicated properly. In …

See researchers on this project
Principal Investigator:
  • Don van Meyel, Research Institute of the McGill University Health Centre
Team Members:
  • Keith Murai, Research Institute of the McGill University Health Centre
  • Adriana Di Polo, CHUM Research Centre, University of Montréal
  • Tim Murphy, University of British Columbia

Cytosolic DNA sensing in ALS-related neuroinflammation

Project Overview

Recently, Dr. Honglin Luo, in collaboration with Dr. Neil Cashman, discovered that mutations in the ALS-linked SOD1 gene result in activation of a specific neuroinflammatory pathway called cGAS-STING. Neuroinflammation is thought to play an important role in the progression of ALS and activation of …

See researchers on this project
Principal Investigator:
  • Honglin Luo, University of British Columbia
Team Members:
  • Neil Cashman, University of British Columbia

Deciphering eEF2K biological functions for therapeutic targeting of neural tumours

Project Overview

In childhood, medulloblastoma (a form of brain cancer) and neuroblastoma (a cancer that starts in the nerve cells) can be aggressive and hard to treat. Dr Poul Sorensen’s group is targeting what he believes is the Achilles heel of tumour cells: namely, how they adapt and survive under stress. He h…

See researchers on this project
Principal Investigator:
  • Poul Sorensen, University of British Columbia

Decoding motor cortex circuit abnormalities at ALS onset through combined two-photon imaging in vivo and pharmacogenetics

Project Overview

ALS is a disease that is characterized by degeneration of both upper and lower motor neurons, and while a significant proportion of work has focused on motor neurons in the spinal cord, the motor cortex in the brain, where electrical signals to your muscles originate have clear, but poorly understoo…

See researchers on this project
Principal Investigator:
  • Lisa Topolnik, CHUQ Research Centre, Laval University